Allergen-specific immunotherapy with Der p 1/2 mRNA vaccines relieves house-dust-mite-induced allergic airway inflammation in a mouse model
Top Cited Papers
- 2 January 2026
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 34 (4) , 2063-2080
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Natural Science Foundation of Beijing Municipality (7264317)
- National Major Science and Technology Projects of China (2019ZX09301131)
- Chinese Academy of Medical Sciences (2021-I2M-1-017)
- National Natural Science Foundation of China (82370041)
- Medical Foundation
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
This publication has 68 references indexed in Scilit:
- Allergen specific immunotherapy regulates macrophage property in the airwaysArchives of Biochemistry and Biophysics, 2024
- Sublingual immunotherapy for 4 years increased the number of Foxp3+ Treg cells, which correlated with clinical effectsInflammation Research, 2021
- Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA DeliveryAdvanced Healthcare Materials, 2021
- Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma2020
- Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 responseEBioMedicine, 2019
- Resolution of allergic asthmaSeminars in Immunopathology, 2019
- Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USAClinical Reviews in Allergy & Immunology, 2019
- Next-Generation of Allergen-Specific Immunotherapies: Molecular ApproachesCurrent Allergy and Asthma Reports, 2018
- Structural biology of mite allergensMolecular Biology Reports, 2012
- Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccinesCellular and Molecular Life Sciences, 2004